Advertisement
Advertisement

CLDX

CLDX logo

Celldex Therapeutics, Inc

24.75
USD
Sponsored
+0.15
+0.59%
Feb 02, 14:11 UTC -5
Open

CLDX Earnings Reports

Positive Surprise Ratio

CLDX beat 28 of 39 last estimates.

72%

Next Report

Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.51M
/
-$1.02
Implied change from Q3 25 (Revenue/ EPS)
--
/
+0.99%
Implied change from Q4 24 (Revenue/ EPS)
+28.19%
/
+43.66%

Celldex Therapeutics, Inc earnings per share and revenue

On Nov 10, 2025, CLDX reported earnings of -1.01 USD per share (EPS) for Q3 25, missing the estimate of -0.91 USD, resulting in a -9.94% surprise. Revenue reached --, compared to an expected 1.01 million, with a -100.00% difference. The market reacted with a +7.50% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analysts forecast an EPS of -1.02 USD, with revenue projected to reach 1.51 million USD, implying an increase of 0.99% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
FAQ
For Q3 2025, Celldex Therapeutics, Inc reported EPS of -$1.01, missing estimates by -9.94%, and revenue of $0.00, -100% below expectations.
The stock price moved up 7.5%, changed from $22.67 before the earnings release to $24.37 the day after.
The next earning report is scheduled for Feb 25, 2026.
Based on 17 analysts, Celldex Therapeutics, Inc is expected to report EPS of -$1.02 and revenue of $1.51M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement